Viewing Study NCT00612027

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-03-05 @ 10:46 AM
Study NCT ID: NCT00612027
Status: COMPLETED
Last Update Posted: 2008-02-11
First Post: 2008-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastrointestinal disorder View
None acid associated gastrointestinal symptoms. View
None esomeprazole therapy in patients with gastrointestinal disorders View
None patients with acid associated gastrointestinal symptoms View